FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to psychiatrics. A clinical examination is combined with recording an electroencephalogram (EEG); its spectral and coherent analyses are carried out. The following values are determined: T6-AA-lead power spectrum within the range of 3.5-5 Hz, F7-AA-lead power spectrum within the range of 2-3 Hz, T5-AA -lead power spectrum within the range of 23-24.5 Hz, hemispheric power asymmetry between F8-AA and F7-AA-leads within the range of 24.5-26 Hz, P4-C4-lead coherence within the range of 8-13 Hz, T4-F8 within the range of 23-24.5 Hz, T3-F7-lead power spectrum within the range of 26-27.5 Hz, T5-O1 within the range of 17-18.5 Hz, T3-F8 within the range of 20-21.5 Hz. Logarithms of the derived values are calculated. An integral diagnostic value is determined by mathematical formula taking into account the calculated logarithm and coefficient-corrective values. If the integral diagnostic value appears to be positive, a recurrent depressive disorder is diagnosed, while a bipolar affective disorder is shown by the negative integral diagnostic value.
EFFECT: method enables providing higher diagnostic reliability at the early stages of the disease that is ensured by the optimum selection of the values, and the mathematical calculation of the integral value.
2 ex
Title | Year | Author | Number |
---|---|---|---|
DIAGNOSTIC TECHNIQUE FOR ANXIOUS AND DEPRESSIVE DISORDERS | 2018 |
|
RU2689886C1 |
METHOD FOR DIAGNOSING AFFECTIVE DISORDER IN PATIENTS WITH ALCOHOL DEPENDENCE ACCORDING TO ELECTROENCEPHALOGRAPHIC STUDIES | 2023 |
|
RU2813702C1 |
METHOD FOR PREDICTING EFFICIENCY OF TRANSCRANIAL MAGNETIC STIMULATION IN TREATING PATIENTS WITH DEPRESSIVE DISORDERS | 2015 |
|
RU2593746C1 |
METHOD FOR PREDICTING EFFECTIVENESS OF TRANSCRANIAL MAGNETIC STIMULATION OF BRAIN IN TREATING PATIENTS WITH DEPRESSIVE DISORDERS | 2019 |
|
RU2688338C1 |
METHOD FOR DIAGNOSING CHRONIC CEREBRAL ISCHEMIA AT THE STAGE OF MODERATE COGNITIVE DISORDERS WITH ACCOMPANYING ANXIETY-DEPRESSIVE DISORDERS | 2019 |
|
RU2719667C1 |
METHOD FOR IDENTIFYING DEPRESSION BASED ON EEG DATA | 2020 |
|
RU2754779C1 |
METHOD FOR DIAGNOSING AUTISM SPECTRUM DISORDERS IN CHILDREN | 2022 |
|
RU2787463C1 |
METHOD OF DIAGNOSTICS OF SCHIZOPHRENIC DISORDER | 2017 |
|
RU2676657C1 |
METHOD FOR DIAGNOSTICS OF MENTAL RETARDATION LINKED TO FRAGILE X CHROMOSOME SYNDROME (FXS) IN CHILDREN AND ADOLESCENTS AGED FROM 3 TO 19 BY DATA OF SPECTRAL EEG ANALYSIS | 2021 |
|
RU2785916C2 |
METHOD OF ESTIMATING EFFICIENCY OF PERFORMED THERAPY OF COGNITIVE DISORDERS AT REHABILITATION STAGE IN PATIENTS WITH VIBRATION DISEASE | 2011 |
|
RU2457779C1 |
Authors
Dates
2014-11-10—Published
2013-07-03—Filed